Nerve Central (Kiernan Lab)

Nerve Central (Kiernan Lab) This 17-strong team of clinicians, scientists, biomedical engineers and research students has a multi-focussed approach to neurological disease.

The Kiernan Group was established in 2001, with research labs based at NeuRA, linked to the Prince of Wales Clinical School UNSW and The Institute of Neurological Sciences, Prince of Wales Hospital. The group works in close collaboration with Professor David Burke at the University of Sydney (combined ARC Discovery grant) and Professor Hugh Bostock FRS at The Institute of Neurology, Queen Square,

London UK (combined fellowships and program grant collaborations). Current projects are directed to:

- motor neurone disease: establishing the site of onset and mechanisms of progression

-spinal cord injury: prevention of neurological damage following injury
multiple sclerosis, demyelinating neuropathy, neuromuscular disease: delineating mechanisms of fatigue

-neurotoxicity: prevention of nerve damage associated with chemotherapies used in the treatment of cancer

-understanding the development of neurological symptoms associated with nerve crush and ischaemia

-epilepsy and pain-related states: improving the effects of anticonvulsant therapies in treatment

-understanding the process of plasticity of the nervous system in stroke patients and thereby finding ways to improve stroke outcome

We are also conducting clinical trials aimed at neuroprotective and physical therapies in neurological diseases. Our research is intrinsically linked to the provision of local clinical services, particularly the multidisciplinary motor neurone disease clinic; the hereditary nerve and muscle clinics run through Prince of Wales Hospitals; neurological consultation and clinical neurophysiological investigations.

05/06/2020
Australia and specifically NSW, featured in the New England Journal of Medicine regarding its control of the Covid-19 pa...
09/05/2020

Australia and specifically NSW, featured in the New England Journal of Medicine regarding its control of the Covid-19 pandemic

02/05/2020

Many people with amyotrophic lateral sclerosis (ALS) and their caregivers wonder how to stay safe during the COVID-19 pandemic. Our expert weighs in.

Doctors Michelle Farrar, Cindy Lin, and William Huynh featured in highlights from the 2019 Australian and New Zealand as...
29/06/2019

Doctors Michelle Farrar, Cindy Lin, and William Huynh featured in highlights from the 2019 Australian and New Zealand association of neurologists annual conference.

07/06/2019

Prof Matthew Kiernan and his Sydney Forefront MND group.

07/06/2019

A new online matching service, StepUp for Dementia Research, is set to revolutionise the way people with dementia and researchers connect, fast-tracking more effective and inclusive dementia research across Australia.

The U.S. Food and Drug Administration today approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy a...
29/05/2019

The U.S. Food and Drug Administration today approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy approved to treat children less than two years of age with spinal muscular atrophy (SMA), the most severe form of SMA and a leading genetic cause of infant mortality.

FDA Approves Innovative Gene Therapy to Treat Pediatric Patients With Spinal Muscular Atrophy, a Rare Disease and Leading Genetic Cause of Infant Mortality

11/05/2019

Research shows that dance offers a wealth of anti-aging benefits. It’s also fun.

Just hot off the Press! Dr William Huynh and Professor Matthew Kiernan published book chapter on Motor Neuron Disease
04/05/2019

Just hot off the Press! Dr William Huynh and Professor Matthew Kiernan published book chapter on Motor Neuron Disease

04/05/2019
27/03/2019

Results from the International Stroke Conference 2019: Dr Christoph Diener discusses recent positive and neutral trial results.

19/03/2019

The first study of its kind involving more than 400,000 members of the general population used an Apple Watch to identify irregular pulse and received a mixed response from ACC delegates.

19/03/2019

Editorial from The New England Journal of Medicine — Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI

12/02/2019

Using perfusion imaging selection of patients presenting 4.5-9 hours after stroke onset or with WUS, functional improvement was seen with at 3 months with alteplase vs placebo. http://spr.ly/6181ER0kN

30/01/2019

A new study shows a low rate of recurrent stroke with up to 17 years of follow-up. It also questions the need for lifelong use of aspirin in these patients.

26/01/2019

New data and recommendations in neurology: Dr Christoph Diener discusses results from randomized studies and guidelines for practice.

The benefits of the cholesterol-lowering medicine called statins far outweigh any risk of side effects, according to a n...
13/12/2018

The benefits of the cholesterol-lowering medicine called statins far outweigh any risk of side effects, according to a new analysis of decades of scientific research.

In fact, side effects of statins are rare, according to a new American Heart Association scientific statement

Statins are safe medications, and people with or at risk for heart disease and stroke should take them as directed, according to a new scientific statement from the American Heart Association.

"moving more and sitting less"
12/11/2018

"moving more and sitting less"

Updated guidelines include new recommendations for children aged 3 to 5, and highlight science supporting new benefits from "moving more and sitting less."

05/11/2018

Dr Justin Yerbury is a world expert in motor neurone disease, a disease that is also slowly killing him. To continue his search for a cure, he chose radical life-prolonging surgery with a hefty after-care cost, prompting the question — what price a life?

19/10/2018
17/10/2018

Address

Neuroscience Research Australia & Institute Of Neurological Sciences (Prince Of Wales Hospital)
Sydney, NSW
2031

Telephone

+61293822413

Website

https://www.facebook.com/JNNP.BMJ

Alerts

Be the first to know and let us send you an email when Nerve Central (Kiernan Lab) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Videos

Share


Other Health/Medical/ Pharmaceuticals in Sydney

Show All